<DOC>
	<DOC>NCT01472848</DOC>
	<brief_summary>This study examines whether a gradual increase of dose improves the gastrointestinal tolerability (nausea and vomiting) of PF05212389</brief_summary>
	<brief_title>A Study Of Gastrointestinal Tolerability Of PF05212389 In Obese Subjects</brief_title>
	<detailed_description />
	<criteria>Obesity Diabetes mellitus (type 1 or type 2) Heart failure Eating disorders Psychiatric disorders History of suicide attempt History of pancreatitis</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>November 2011</verification_date>
</DOC>